Adaptimmune Therapeutics PLC (ADAPY) bonds
ADAPYOTCBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$0.04+0.00 (+9.38%)
Close on Oct 19, 2026Market cap $55.46MP/E –Yield –
Debt
Borrowings on the balance sheet, Jun 30, 2025
Total debt
$25.68M
Long-term debt
Net debt
-$386.00K
After $26.06M of cash
Implied interest rate
–
FY2024 interest ÷ average debt
Interest coverage
-20.5×
FY2024 operating income ÷ interest
Total debt by fiscal year
Long-term plus current debt, USD
Notes and loans outstanding
As tagged in Adaptimmune Therapeutics's 10-Q for the period ended Jun 30, 2025
| Issue | Amount issued | Carrying value |
|---|---|---|
| Loan and Security Agreement | $125.00M | $25.00M |
Companies tag their debt differently: some list every note, others group notes by issuance year or by type, so the list may not add up to total debt. Notes that matured before today are hidden. Source: 10-Q.
See a number that looks wrong?